Market closedADR

Hutchmed/$HCM

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX

About Hutchmed

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

Ticker

$HCM
Trading on

Industry

Pharmaceuticals

Headquarters

Hong Kong, Hong Kong

Employees

1,811

Hutchmed Metrics

BasicAdvanced
$2.6B
365.01
$0.04
0.75
-
$2.6B
0.75
$17.08
$11.51
112K
2.832
2.677
8.23
11.637
-15.22%
-2.14%
5.04%
365.009
19.816
2.54
2.55
-716.248
-24.80%
-66.28%
20.96%
-45.71%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.

Buy $HCM

Sign up or log in to buy
Capital at risk
Market closedADR

Upcoming events

No upcoming events
FAQs

What’s the current market cap for Hutchmed stock?

What is the P/E ratio for Hutchmed stock?

Does Hutchmed stock pay dividends?

When is the next Hutchmed dividend payment date?

What is the beta indicator for Hutchmed?